PRESS RELEASE

from MPH Health Care AG (isin : DE000A289V03)

MPH Health Care AG announces placement of shares in M1 Kliniken AG

EQS-News: MPH Health Care AG / Key word(s): Disposal
MPH Health Care AG announces placement of shares in M1 Kliniken AG

19.11.2026 / 17:40 CET/CEST
The issuer is solely responsible for the content of this announcement.


MPH Health Care AG announces placement of shares in M1 Kliniken AG


The issuer is solely responsible for the content of this announcement.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION COULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PUBLICATION.
 
  • MPH Health Care AG (“MPH”) intends to sell up to 927,755 existing shares in M1 Kliniken AG (“M1”), representing approximately 5 per cent of the issued share capital, to institutional investors by way of an accelerated bookbuilding offering
  • Assuming full placement, MPH’s shareholding in M1 would decrease from approximately 66 per cent to approximately 61 per cent; MPH would thus remain the majority shareholder
  • The transaction is intended to increase the free float of M1, broaden the institutional shareholder base and strengthen the trading liquidity of the M1 share on a sustained basis

Berlin, 19 November 2026 – MPH Health Care AG (ISIN: DE000A289V03; “MPH”) intends to sell up to 927,755 existing no-par value bearer shares in M1 Kliniken AG (ISIN: DE000A0STSQ8; “M1”) to institutional investors by way of a private placement through an accelerated bookbuilding process. The final placement price and the number of shares actually placed will be determined in the course of the bookbuilding process.


“With the planned placement, we aim to broaden the institutional shareholder base and enhance the tradability of the M1 share. At the same time, our continued majority shareholding underlines our long-term commitment to M1 and to the further development of the company.”
-  Patrick Brenske, CEO of MPH Health Care AG

Assuming full placement, MPH would continue to hold approximately 11.4 million M1 shares and would thus remain the majority shareholder. The placement will be made exclusively from MPH’s existing shareholding.

M1 is the central holding within MPH’s portfolio and operates 59 clinics in ten countries under the M1 Med Beauty brand.

Transaction details
  • The bookbuilding is to commence immediately after publication of this announcement on 19 November 2026, following the close of trading on Xetra. The order book may be closed at short notice. The price and the placement size will be determined upon completion of the process; the results of the placement are expected to be announced on or around 19 November 2026.
  • The shares offered carry full dividend entitlement for the financial year 2026.
  • MPH entered into a three-month lock-up undertaking in respect of its M1 shares remaining after the placement, subject to customary exceptions.
  • Trade Date is scheduled for 20 November 2026 and Settlement Date is scheduled for 24 November 2026.
  • Cantor is acting as Sole Global Coordinator and Sole Bookrunner for the placement.

About MPH Health Care AG
MPH Health Care AG is a listed investment holding company headquartered in Berlin. Its focus is on the development and long-term value creation of equity investments, particularly in growth segments of the healthcare market. M1 Kliniken AG is MPH’s strategic core holding.

Investor Relations
MPH Health Care AG
Grünauer Straße 5
12557 Berlin
ir@mph-ag.de

Important Notice:
This announcement may not be released, published or distributed, directly or indirectly, in the United States of America (including its territories and possessions), Australia, Canada, Japan, South Africa or any other jurisdiction where such publication could be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons who are in possession of this announcement or other information referred to herein should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.
This announcement does not constitute an offer of, or a solicitation of an offer to purchase, securities of M1 Kliniken AG or of any of its subsidiaries in the United States of America, Germany or any other jurisdiction. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, an offer in any jurisdiction. The securities offered are not and have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act. No public offering of securities is being made in the United States.
In member states of the European Economic Area, the placement of securities described in this announcement is directed exclusively at persons who are “qualified investors” within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (Prospectus Regulation), as amended.
In the United Kingdom, the placement of securities described in this announcement is directed exclusively at persons who are “qualified investors” within the meaning of paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024, and who are persons who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) or (iii) to whom it may otherwise be lawfully communicated (all such persons together being referred to as “Relevant Persons”). This announcement must not be acted on, or relied upon, by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.
No action has been taken that would permit an offering or an acquisition of the securities or a distribution of this announcement in any jurisdiction where such action would be unlawful. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.



Contact:
Patrick Brenske, Management Board
Corporate Communications
E-Mail: ir@mph-ag.de


19.11.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Germany
Phone:030 / 863 21 45 60
Fax:030 / 863 21 45 69
E-mail:info@mph-ag.de
Internet:www.mph-ag.de
ISIN:DE000A289V03
WKN:A289V0
Listed:Regulated Unofficial Market in Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate BSX
LEI Code:529900RLXP5HZXHVCT80
EQS News ID:2438898

 
End of NewsEQS News Service

2438898  19.11.2026 CET/CEST

See all MPH Health Care AG news